From AVAC <[email protected]>
Subject How to be #HIVvaccineaware this #HVAD2021
Date May 18, 2021 2:58 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
** How to be #HIVvaccineaware this #HVAD2021
------------------------------------------------------------
May 18, 2021

Dear Advocate,

Today, May 18th, is HIV Vaccine Awareness Day (HVAD), and advocates are calling for policies, science and advocacy for HIV vaccines that leverage the lessons of the past year.

This HVAD, we are focused on how the COVID experience can speed the development AND delivery of vaccines for HIV, TB, malaria and other diseases. Below you’ll find a roundup of resources, from AVAC and others, providing context, key messages and other information on what the field has learned from COVID-19, the essential role of vaccines in global health, and what’s next in the search for an HIV vaccine.

** Vaccines & Global Health in Perspective
------------------------------------------
* In a commentary today in Bhekisisa ([link removed]), Fatima Hassan of Health Justice Initiative and AVAC’s Mitchell Warren outline Finding an HIV vaccine: Five lessons from the response to COVID-19 ([link removed]) .

* Episode 1 of the new podcast from the International AIDS Society (IAS), HIV Unmuted ([link removed]) takes listeners to the global HIV change-makers who have shaped the response and asks what must happen now to end the AIDS epidemic. This debut episode features the NIH’s ([link removed]) Anthony Fauci, AVAC’s Maureen Luba, Udom Likhitwonnawut from Thailand’s National Community Advisory Board, and others.

* USAID’s Ashley Lima and Margaret McCluskey on How HIV Vaccine Advocacy Can Leverage Lessons from COVID-19, ([link removed]) drawing on the experiences and perspective of CASPR ([link removed]) partners and their agenda for vaccine advocacy in the midst of COVID.

** AVAC’s HVAD Package
----------------------
Check out AVAC’s key messages ([link removed]) for this HVAD. Designed for easy communication, this resource outlines the six ways that the COVID experience can shape HIV vaccine advocacy moving forward. For social media, we hope our sample tiles and tweets will inspire action to keep audiences #HIVvaccineaware this #HVAD2021. Download tiles at avac.org/hvad.

Get the basics with AVAC’s annually updated powerpoint tutorial ([link removed]) on HIV vaccines; current and planned vaccine research with this table of clinical trials ([link removed]); and our infographics gallery ([link removed]) allows you to search by prevention intervention. All of these resources and more are up at www.avac.org/hvad.

** IAVI’s HVAD Resources
------------------------
We encourage you to explore IAVI’s #HVAD2021 toolkit ([link removed]) for the perspectives of scientists and community liaison teams, videos on the science and development of vaccines, and tiles and tweets supporting their HVAD campaign at #EyesOnTheTarget and more.

** Updates from the Field
-------------------------
* Earlier today, WACI Health ([link removed]) and AfNHI ([link removed]) hosted a webinar exploring the remarkable advances in HIV vaccine research and the promising concepts being studied today with Ntando Yola, of APHA-South Africa ([link removed]) and the Desmond Tutu Health Foundation, and Nyaradzo Mgodi, clinical pathologist from the University of Zimbabwe. Look for a recording of the webinar at avac.org/hvad, along with recordings of two additional webinars: one co-hosted by IAVI and KANCO ([link removed]) featuring leading researchers and advocates in East Africa and one co-hosted by IAVI and SANAC featuring leaders in South Africa.

* On May 13th, AVAC hosted a webinar HIV Vaccines in the Midst of COVID ([link removed]). In this recording ([link removed]) you’ll hear researchers and advocates discussing new vaccine technologies, delivery challenges, community engagement, and confidence in both vaccines and vaccine research.

* In the latest episode of AVAC’s Px Pulse podcast, Dive into the AMP Trials ([link removed]), we unpack the results of the recent Antibody-Mediated Prevention (AMP) studies, which will inform the fields of antibodies-for-prevention, and HIV vaccine research.

We can make #HVAD2021 the turning point, when the full potential of vaccines becomes undeniable, and the world renews its commitment to the search for vaccines for HIV, TB and other diseases that continue to threaten so many people’s health and wellbeing.

Best,
AVAC

============================================================
Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe

Contact Us T: +1 212 796 6423
E: ** [email protected]
W: ** www.avac.org
** www.twitter.com/hivpxresearch
** www.facebook.com/hivpxresearch
** www.youtube.com/hivpxresearch
==============================================

Unsubscribe [email protected] from this list:
[link removed]
Screenshot of the email generated on import

Message Analysis